Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
It is intended solely for laboratory research and analytical purposes by qualified professionals
This is a massive dose of hormone that affects not only the gut, but the entire body, with major implications for eating processes and eating disorders
The drug met the primary and key secondary endpoints, delivering superior A1C reduction and Lillys triple agonist achieves 16.8% weight loss in phase 3 trial Eli Lillys triple agonist, retatrutide, demonstrated an average weight loss of 16.8% in a Phase 3 trial for the treatment of type 2 diabetes, the company announced today
Dosage should be determined through individual clinical assessment with a qualified healthcare provider
Discover the differences in results, side effects, and ingredients to help you and your doctor decide
US$ 24.71
US$ 22.34
US$ 26.90
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 28.97
